Search

Your search keyword '"Kelly, W.K."' showing total 3 results
Start Over Author "Kelly, W.K." Topic castration-resistant prostate cancer
3 results on '"Kelly, W.K."'

1. 1598P Xaluritamig, a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Initial results from dose expansion cohorts in a phase I study.

Author

Kelly, W.K., Appleman, L.J., Lin, C-C., Armstrong, A.J., Fischer, S.C., Pook, D.W., Perez Gracia, J.L., Lee, J.L., Berthold, D.R., Ward, P.J., Castellano Gauna, D.E., Horvath, L.G., Kim, M., Matsubara, N., Sumey, C., Shabooti, M., Yang, Z., Connarn, J., Stieglmaier, J., and Danila, D.C.

Subjects
*CASTRATION-resistant prostate cancer, *CD3 antigen
Published
2024
Full Text
View/download PDF

2. 264P Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).

Author

Kelly, W.K., Danila, D.C., Lin, C-C., Lee, J-L., Matsubara, N., Ward, P.J., Armstrong, A.J., Pook, D.W., Kim, M., Dorff, T., Fischer, S., Lin, Y-C., Horvath, L.G., Sumey, C., Yang, Z., Jurida, G., Connarn, J., Penny, H., Stieglmaier, J., and Appleman, L.J.

Subjects
*CASTRATION-resistant prostate cancer, *CD3 antigen
Published
2023
Full Text
View/download PDF

3. 1610P Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig.

Author

Armstrong, A.J., Appleman, L.J., Danila, D.C., Lin, C-C., Lee, J.L., Matsubara, N., Ward, P.J., Pook, D.W., Kim, M., Dorff, T.B., Fischer, S.C., Lin, Y-C., Horvath, L.G., Sumey, C., Yang, Z., Decato, B.E., Englert, J.M., Smith, K.M., Lolkema, M., and Kelly, W.K.

Subjects
*CASTRATION-resistant prostate cancer, *OVERALL survival, *TUMORS
Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results